Benzquinamide
![]() | |
Systematic (IUPAC) name | |
---|---|
3-(Diethylcarbamoyl)-9,10-dimethoxy-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-yl acetate | |
Clinical data | |
Trade names | Promecon, Quantril, Emete-Con |
Licence data | US FDA:link |
Routes of administration | Suppository, injection |
Identifiers | |
CAS Number |
63-12-7 ![]() |
ATC code | None |
IUPHAR/BPS | 7124 |
DrugBank |
DB00767 ![]() |
ChemSpider |
2252 ![]() |
UNII |
0475EA27Q3 ![]() |
KEGG |
D00243 ![]() |
ChEMBL |
CHEMBL1201250 ![]() |
Chemical data | |
Formula | C22H32N2O5 |
Molar mass | 404.5 g/mol |
| |
| |
![]() ![]() |
Benzquinamide is a discontinued antiemetic drug used in post-operative care. It was first synthesised by Pfizer in the 1960s.[1][2]
References
This article is issued from Wikipedia - version of the Saturday, January 30, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.